Items where authors include "Iyer, V"

Article

Birkeälv, S, Harland, M, Matsuyama, LSAS et al. (15 more authors) (2023) Mutually exclusive genetic interactions and gene essentiality shape the genomic landscape of primary melanoma. Journal of Pathology, 259 (1). pp. 56-68. ISSN 0022-3417

Simonin-Wilmer, I, Ossio, R, Leddin, EM et al. (14 more authors) (2022) Population-based analysis of POT1 variants in a cutaneous melanoma case–control cohort. Journal of Medical Genetics (JMG). ISSN 0022-2593

Castaneda-Garcia, C, Iyer, V, Nsengimana, J et al. (11 more authors) (2022) Defining novel causal SNPs and linked phenotypes at melanoma-associated loci. Human Molecular Genetics, 31 (17). pp. 2845-2856. ISSN 0964-6906

Voysey, M, Costa Clemens, SA, Madhi, SA et al. (763 more authors) (2021) Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials. The Lancet, 397 (10277). pp. 881-891. ISSN 0140-6736

Artomov, M, Stratigos, AJ, Kim, I et al. (21 more authors) (2017) Rare Variant, Gene-Based Association Study of Hereditary Melanoma Using Whole-Exome Sequencing. JNCI: Journal of the National Cancer Institute, 109 (12). djx083. ISSN 0027-8874

O'Shea, SJ orcid.org/0000-0002-1588-6022, Robles-Espinoza, C, McLellan, L et al. (10 more authors) (2017) A population-based analysis of germline BAP1 mutations in melanoma. Human Molecular Genetics, 26 (4). pp. 717-728. ISSN 0964-6906

Preprint

Ranzani, M, Kemper, K, Michaut, M et al. (35 more authors) (2017) A screen for combination therapies in<i>BRAF/NRAS</i>wild type melanoma identifies nilotinib plus MEK inhibitor as a synergistic combination. [Preprint]